News

News

Hikma delivers strong performance in 2020

News

News

Hikma donates over $4 million USD in medicines and signs new long-term partnerships with Dispensary of Hope, Direct Relief, Americares, Brother’s Brother Foundation, and the National Children’s Cancer Society

Upcoming event

Upcoming event

Meet the Management series for investors and analysts

Preliminary 2020 Results

Watch our CEO Siggi Olafsson summarise our 2020 full year results

#OwnYour Career @Hikma

#OwnYour Career @Hikma

Our Analytical Research Manager, Rita tells us about her job and what excites her the most about her role​.

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

Insight

Insight

Kept out of reach - tackling the enduring challenge of access to medicine

Update

Update

Hikma update regarding COVID-19

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

News

News

Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.